Higher BMI Linked to Superior Survival in mCRPC
Oncology Nursing News,
Patients with metastatic castration-resistant prostate cancer (mCRPC) who are obese report better disease specific and overall…
Randomized, Open-Label Phase III Trial of Docetaxel Plus High-Dose Calcitriol Versus Docetaxel Plus Prednisone for Patients With Castration-Resistant Prostate Cancer
Overview of attention for article published in Journal of Clinical Oncology, April 2011
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (95th percentile)
-
High Attention Score compared to outputs of the same age and source (88th percentile)
Readers on
- mendeley
- 119 Mendeley
